Loeb's Third Point Discloses 8.7% Stake in Candela (CLZR)
In a 13G filing on Candela Corporation (Nasdaq: CLZR), Daniel Loeb's Third Point LLC disclosed an 8.7% stake (2 million shares) in the company. The firm did not show a stake in CLZR for the quarter ended 12/31/06.
A 13G filing indicates a "passive" stake, but Loeb is known as an activist investors. On Friday, Loeb also disclosed a new 5%+ stake in DepoMed Inc. (Nasdaq: DEPO).
Candela manufactures, and distributes innovative clinical solutions that enable physicians, surgeons, and personal care practitioners to treat selected cosmetic and medical conditions using lasers, aesthetic laser systems, and other advanced technologies.
A 13G filing indicates a "passive" stake, but Loeb is known as an activist investors. On Friday, Loeb also disclosed a new 5%+ stake in DepoMed Inc. (Nasdaq: DEPO).
Candela manufactures, and distributes innovative clinical solutions that enable physicians, surgeons, and personal care practitioners to treat selected cosmetic and medical conditions using lasers, aesthetic laser systems, and other advanced technologies.
Labels: Candeal Corp, CLZR, Daniel Loeb, Third Point LLC
0 Comments:
Post a Comment
<< Home